###begin article-title 0
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human TLR1 Deficiency Is Associated with Impaired Mycobacterial Signaling and Protection from Leprosy Reversal Reaction
###end article-title 0
###begin p 1
Conceived and designed the experiments: EM MM CR BS RW MS GK TH. Performed the experiments: EM CR BS RW MS TH. Analyzed the data: EM MM CR BS RW MS GK TH. Contributed reagents/materials/analysis tools: EM MM MS TH. Wrote the paper: EM MM GK TH.
###end p 1
###begin p 2
###xml 106 126 106 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium leprae</italic>
###xml 535 544 535 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. leprae</italic>
###xml 800 809 796 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. leprae</italic>
###xml 106 126 <span type="species:ncbi:1769">Mycobacterium leprae</span>
###xml 535 544 <span type="species:ncbi:1769">M. leprae</span>
###xml 800 809 <span type="species:ncbi:1769">M. leprae</span>
###xml 987 995 <span type="species:ncbi:9606">patients</span>
Toll-like receptors (TLRs) are important regulators of the innate immune response to pathogens, including Mycobacterium leprae, which is recognized by TLR1/2 heterodimers. We previously identified a transmembrane domain polymorphism, TLR1_T1805G, that encodes an isoleucine to serine substitution and is associated with impaired signaling. We hypothesized that this TLR1 SNP regulates the innate immune response and susceptibility to leprosy. In HEK293 cells transfected with the 1805T or 1805G variant and stimulated with extracts of M. leprae, NF-kappaB activity was impaired in cells with the 1805G polymorphism. We next stimulated PBMCs from individuals with different genotypes for this SNP and found that 1805GG individuals had significantly reduced cytokine responses to both whole irradiated M. leprae and cell wall extracts. To investigate whether TLR1 variation is associated with clinical presentations of leprosy or leprosy immune reactions, we examined 933 Nepalese leprosy patients, including 238 with reversal reaction (RR), an immune reaction characterized by a Th1 T cell cytokine response. We found that the 1805G allele was associated with protection from RR with an odds ratio (OR) of 0.51 (95% CI 0.29-0.87, p = 0.01). Individuals with 1805 genotypes GG or TG also had a reduced risk of RR in comparison to genotype TT with an OR of 0.55 (95% CI 0.31-0.97, p = 0.04). To our knowledge, this is the first association of TLR1 with a Th1-mediated immune response. Our findings suggest that TLR1 deficiency influences adaptive immunity during leprosy infection to affect clinical manifestations such as nerve damage and disability.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 0 20 0 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium leprae</italic>
###xml 908 920 908 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacteria</italic>
###xml 1106 1114 1106 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 0 20 <span type="species:ncbi:1769">Mycobacterium leprae</span>
###xml 22 24 <span type="species:ncbi:1769">ML</span>
###xml 122 124 <span type="species:ncbi:1769">ML</span>
###xml 159 165 <span type="species:ncbi:9606">humans</span>
###xml 740 745 <span type="species:ncbi:9606">human</span>
###xml 1033 1039 <span type="species:ncbi:9606">humans</span>
###xml 1103 1105 <span type="species:ncbi:1769">ML</span>
###xml 1301 1303 <span type="species:ncbi:1769">ML</span>
Mycobacterium leprae (ML) causes a disabling and stigmatizing disease that is characterized by distinct immune responses. ML produces a spectrum of illness in humans, and several lines of evidence indicate that host genetic factors influence susceptibility and clinical manifestations. Leprosy can occur as the lepromatous or tuberculoid forms, which are associated with different clinical manifestations, histopathology, T cell cytokine profiles, and bacterial burden in affected sites. Leprosy is also associated with unique immunologic reactions, such as reversal reaction, which is characterized by the rapid development of a Th1 T cell cytokine response that can cause substantial morbidity. We and others recently discovered a common human polymorphism in TLR1 (T1805G, I602S) that regulates cytokine production in response to lipopeptide stimulation, influences the cellular innate immune response to Mycobacteria, is associated with altered localization, and is present in 50% of individuals worldwide. Here, we show that in humans the 1805G variant does not mediate an inflammatory response to ML in vitro and that this polymorphism is associated with protection from reversal reaction. These data suggest that a common variant of TLR1 is associated with altered adaptive immune responses to ML as well as clinical outcome.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 0 26 0 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 187 190 187 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Berrington1">[1]</xref>
###xml 192 212 192 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium leprae</italic>
###xml 351 354 351 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Casanova1">[2]</xref>
###xml 0 26 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 28 31 <span type="species:ncbi:1773">MTb</span>
###xml 192 212 <span type="species:ncbi:1769">Mycobacterium leprae</span>
###xml 214 216 <span type="species:ncbi:1769">ML</span>
###xml 361 364 <span type="species:ncbi:1773">MTb</span>
###xml 369 371 <span type="species:ncbi:1769">ML</span>
###xml 528 531 <span type="species:ncbi:1773">MTb</span>
###xml 536 538 <span type="species:ncbi:1769">ML</span>
Mycobacterium tuberculosis (MTb) has established latent infection in one-third of the world's population and, among those with progressive disease, causes about 2 million deaths per year [1]. Mycobacterium leprae (ML), a related organism, is the etiologic agent of leprosy, an ancient scourge that still causes illness in several regions of the world [2]. Both MTb and ML produce a spectrum of illness in their hosts, yet, aside from frank immunodeficiency, the host factors that underlie the various clinical manifestations of MTb and ML infection are largely unknown. One possible explanation for this diversity of outcomes is common, subclinical variation in host defense genes.
###end p 6
###begin p 7
###xml 101 113 101 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacteria</italic>
###xml 113 116 113 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Berrington1">[1]</xref>
###xml 117 120 117 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Alcais1">[5]</xref>
###xml 306 309 306 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Casanova1">[2]</xref>
###xml 750 753 750 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Casanova1">[2]</xref>
###xml 908 911 908 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Chakravartti1">[6]</xref>
###xml 1184 1187 1184 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Casanova1">[2]</xref>
###xml 1188 1191 1188 1191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Schurr1">[7]</xref>
###xml 1192 1195 1192 1195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Siddiqui1">[8]</xref>
###xml 1335 1336 1335 1336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 1343 1346 1343 1346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Alcais2">[9]</xref>
###xml 1371 1375 1371 1375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Roy1">[10]</xref>
###xml 1387 1391 1383 1387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Santos1">[11]</xref>
###xml 1403 1407 1399 1403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Wibawa1">[12]</xref>
###xml 1436 1440 1432 1436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-deMessiasReason1">[13]</xref>
###xml 1441 1445 1437 1441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Dornelles1">[14]</xref>
Several lines of evidence suggest that genetic factors influence susceptibility to leprosy and other Mycobacteria[1]-[5]. Rare individuals with primary immunodeficiency syndromes are highly susceptible to certain mycobacterial species due to Mendelian disorders associated with highly penetrant phenotypes [2]. However, in most individuals, susceptibility to mycobacterial infection is associated with complex inheritance patterns that are determined by the combined effects of variation across many genes, with a modest contribution from each polymorphism. Evidence that commonly inherited gene variants influence susceptibility to mycobacterial infection comes from twin studies, genome-wide linkage studies, and candidate gene association studies [2]. Studies of leprosy infection in twins have shown a three-fold greater concordance for type of leprosy disease in monozygotic compared to dizygotic twins [6]. Genome-wide linkage studies have identified two single nucleotide polymorphisms (SNPs) in the shared promoter region of the PARK2 and the PARCG gene, several HLA-DR2 alleles, and a non-HLA region near chromosome 10p13 that are associated with leprosy or leprosy subtypes [2],[7],[8]. Candidate gene association studies have also shown associations between leprosy and polymorphisms in several genes, including lymphotoxin-a (LTA) [9], the vitamin D receptor [10], TNF-alpha [11], laminin-2 [12], and mannose binding lectin [13],[14].
###end p 7
###begin p 8
###xml 21 30 21 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. leprae</italic>
###xml 637 641 637 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Scollard1">[15]</xref>
###xml 642 646 642 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Britton1">[16]</xref>
###xml 1014 1018 1014 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Scollard1">[15]</xref>
###xml 1019 1023 1019 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Britton1">[16]</xref>
###xml 1079 1083 1079 1083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Ranque1">[17]</xref>
###xml 1162 1166 1162 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Cardoso1">[18]</xref>
###xml 1167 1171 1167 1171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Bochud1">[19]</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 21 30 <span type="species:ncbi:1769">M. leprae</span>
###xml 566 568 <span type="species:ncbi:1769">ML</span>
###xml 738 740 <span type="species:ncbi:1769">ML</span>
###xml 805 813 <span type="species:ncbi:9606">patients</span>
Human infection with M. leprae presents a unique opportunity to link innate and adaptive immune responses to host genetic factors. Leprosy's divergent clinical forms reflect two distinct immune responses to the same pathogen. Lepromatous leprosy (defined as polar lepromatous (LL) or borderline lepromatous (BL)) is characterized by a Th2 immune response and poor containment of the infection. At the opposite pole, tuberculoid leprosy (defined as polar tuberculoid (TT) or borderline tuberculoid (BT)) features a Th1 cytokine response, vigorous T cell responses to ML antigen, and containment of the infection in well-formed granulomas [15],[16]. Reversal reactions (RR) represent the sudden activation of a Th1 inflammatory response to ML antigens. They often occur after the initiation of treatment in patients towards the lepromatous pole of the leprosy spectrum (LL, BL, or borderline borderline (BB) categories) and reflect a switch from a Th2-predominant cytokine response toward a Th1-predominant response [15],[16]. Risk factors for RR intrinsic to the host include age [17] and gene variants, although the latter have not been intensively investigated [18],[19].
###end p 8
###begin p 9
###xml 217 221 217 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Akira1">[20]</xref>
###xml 222 226 222 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Beutler1">[22]</xref>
###xml 350 354 350 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Underhill1">[23]</xref>
###xml 355 359 355 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Tapping1">[26]</xref>
###xml 608 611 608 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Berrington1">[1]</xref>
###xml 612 616 612 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Heldwein1">[27]</xref>
###xml 617 621 617 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Quesniaux1">[28]</xref>
###xml 790 794 790 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Akira1">[20]</xref>
###xml 921 925 921 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Krutzik1">[29]</xref>
###xml 926 930 926 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Bochud2">[30]</xref>
###xml 1035 1039 1035 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Ogus1">[31]</xref>
###xml 1040 1044 1040 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Yim1">[33]</xref>
###xml 400 403 <span type="species:ncbi:9606">Man</span>
###xml 405 409 <span type="species:ncbi:9606">OMIM</span>
###xml 448 452 <span type="species:ncbi:9606">OMIM</span>
###xml 471 475 <span type="species:ncbi:9606">OMIM</span>
###xml 910 912 <span type="species:ncbi:1769">ML</span>
###xml 917 920 <span type="species:ncbi:1773">MTb</span>
###xml 1031 1034 <span type="species:ncbi:1773">MTb</span>
Toll-like receptors (TLRs) are a family of highly conserved, type 1 transmembrane proteins that orchestrate the innate immune response to microbial motifs, also known as pathogen associated molecular patterns (PAMPs) [20]-[22]. The TLR pathway regulates the innate immune response to mycobacteria through several TLRs, including TLR1, 2, 4, 6, and 9 [23]-[26]. TLR2 (Online Mendelian Inheritancce in Man (OMIM):603028), as a heterodimer with TLR1 (OMIM: 601194) or TLR6 (OMIM: 605403), mediates recognition of several mycobacterial motifs, including lipopeptides, the 19 kDa protein, lipoarabinomannan (LAM) [1],[27],[28]. Interaction of these ligands with the extracellular domain of TLRs leads to activation of a signaling pathway, which results in expression of chemokines and cytokines [20]. Functional work by many investigators has shown that TLR2 is a critical mediator of the innate immune response to ML and MTb [29],[30]. In addition, several TLR2 polymorphisms have been reported to be associated with susceptibility to MTb [31]-[33].
###end p 9
###begin p 10
###xml 290 294 290 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Agrawal1">[34]</xref>
###xml 295 299 295 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Gavin1">[37]</xref>
###xml 474 478 474 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Hawn1">[38]</xref>
###xml 614 618 614 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Johnson1">[39]</xref>
###xml 759 763 759 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Johnson1">[39]</xref>
###xml 607 613 <span type="species:ncbi:9103">Turkey</span>
###xml 936 938 <span type="species:ncbi:1769">ML</span>
By contrast, very little is known about the effect of TLR1 variation on the innate response to mycobacteria or clinical susceptibility to mycobacterial disease. It also remains controversial whether and how the innate immune response mediated by any individual TLR shapes adaptive immunity [34]-[37]. We recently characterized a non synonymous SNP, T1805G (I602S), in the transmembrane domain of TLR1 that regulates signaling in response to PAM3, a synthetic ligand of TLR1 [38]. Johnson et al. also found that this polymorphism was associated with decreased signaling as well as protection from leprosy in Turkey [39]. Intriguingly, it appears that the TLR1 signaling defect is due to a complete absence of TLR1 on the surface of monocytes in GG individuals [39]. Here, we investigate an association of this SNP with different clinical forms of leprosy in Nepal and examine the effect of this SNP on leukocyte signaling in response to ML stimulation.
###end p 10
###begin title 11
Methods
###end title 11
###begin title 12
Materials
###end title 12
###begin p 13
###xml 152 172 152 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Salmonella minnesota</italic>
###xml 387 390 387 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bis</italic>
###xml 406 407 406 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 470 491 470 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycoplasma fermentens</italic>
###xml 562 571 562 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. leprae</italic>
###xml 152 172 <span type="species:ncbi:70803">Salmonella minnesota</span>
###xml 562 571 <span type="species:ncbi:1769">M. leprae</span>
###xml 777 780 <span type="species:ncbi:9685">cat</span>
###xml 823 829 <span type="species:ncbi:9913">bovine</span>
RPMI Medium 1640, L-glutamine, penicillin-streptomycin, and DMEM were from GIBCO/Invitrogen (Carlsbad, CA). Ultrapure lipopolysaccharide (LPS) was from Salmonella minnesota R595 (List Biological Labs, Inc.). Lipopeptides PAM2Cys-SKKKK (diacylated, PAM2) and PAM3Cys-SKKK (triacylated, PAM3) were from EMC Microcollections (Tuebingen, Germany). Macrophage-activating Lipopeptide-2 S-[2,3-bis(Palmityloxy)-(2R)-propyl-cysteinyl-GNNDESNISFKEK] (diacylated lipopeptide from Mycoplasma fermentens, Malp-2) was obtained from Alexis Biochemicals (Lausen, Switzerland). M. leprae reagents were obtained from J. Spencer (Colorado State University) through NIH, NIAID Contract No. NO1-AI-25469, entitled "Leprosy Research Support." HEK293 cells (ATCC#CRL-1573) were grown in DMEM (GIBCO cat. no. #11995), supplemented with 10% fetal bovine serum, 10 units/ml penicillin, and 10 microg/ml streptomycin.
###end p 13
###begin title 14
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Subjects and Study Design
###end title 14
###begin p 15
###xml 112 116 112 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Hawn2">[40]</xref>
###xml 811 815 811 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Ridley1">[41]</xref>
###xml 6 18 <span type="species:ncbi:9606">participants</span>
###xml 124 136 <span type="species:ncbi:9606">participants</span>
###xml 167 175 <span type="species:ncbi:9606">patients</span>
###xml 822 829 <span type="species:ncbi:9606">patient</span>
###xml 970 975 <span type="species:ncbi:9606">Human</span>
###xml 1225 1233 <span type="species:ncbi:9606">patients</span>
###xml 1265 1272 <span type="species:ncbi:9606">patient</span>
Study participants in Seattle were healthy adults with no known history of unusual susceptibility to infections [40]. Study participants in Nepal included 933 leprosy patients referred for treatment at Anandaban Hospital in Katmandu, Nepal and later recruited to a study of genetic factors influencing susceptibility to reactional episodes in leprosy. The study population comprised more than 8 different ethnic and religious groups that included Brahmin (25.6%), Chhetri (22.3%), Tamang (14.3%), Newar (7.3%), Magar (5.4%), Muslim (3.3%), Sarki (3.5%), and Kami (2.7%), with 15.5% having unrecorded ethnicity A diagnosis of leprosy and determination of leprosy type was made by clinical symptoms, skin smears and biopsy reports. Assignment of leprosy category followed the Ridley/Jopling classification scheme [41]. Each patient had a minimum of three years of regular clinic follow-up prior to recruitment. In accord with guidelines of the US Department of Health and Human Services, protocols were approved by the Nepal Health Research Council, the University of Washington, the University of Medicine and Dentistry of New Jersey, and the Western Institutional Review Board. Written informed consent was obtained from all patients or from their relatives if the patient could not provide consent.
###end p 15
###begin title 16
Molecular Biology
###end title 16
###begin p 17
###xml 395 399 395 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Hawn3">[42]</xref>
###xml 400 404 400 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Storm1">[43]</xref>
###xml 582 586 582 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Hawn1">[38]</xref>
###xml 714 718 714 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Bochud2">[30]</xref>
DNA from subjects in Nepal was obtained by extraction from whole blood using Nucleon BACC2 Genomic DNA (Amersham Lifesciences) and Roche High-Pure PCR template preparation extraction kits. DNA from subjects in Seattle was extracted from whole blood using QIAamp DNA Blood Midi kits (Qiagen, Valenica, CA). Genotyping was carried out with a MassARRAY technique (Sequenom) as previously described [42],[43]. For functional studies, the coding region of TLR1 was amplified from genomic DNA and cloned into the pEF6/V5-His-TOPO vector (Invitrogen, Carlsbad, CA) as previously described [38]. To obtain the polymorphic variants of TLR1, a whole plasmid PCR strategy with mutant primers was used as previously described [30].
###end p 17
###begin title 18
Cytokine Assays
###end title 18
###begin p 19
###xml 121 122 121 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 329 338 329 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. leprae</italic>
###xml 677 684 677 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Limulus</italic>
###xml 193 199 <span type="species:ncbi:9913">bovine</span>
###xml 329 338 <span type="species:ncbi:1769">M. leprae</span>
###xml 545 550 <span type="species:ncbi:9606">Human</span>
###xml 812 814 <span type="species:ncbi:1769">ML</span>
###xml 816 818 <span type="species:ncbi:1769">ML</span>
###xml 824 826 <span type="species:ncbi:1769">ML</span>
###xml 1021 1023 <span type="species:ncbi:1769">ML</span>
###xml 1028 1030 <span type="species:ncbi:1769">ML</span>
###xml 1059 1061 <span type="species:ncbi:1769">ML</span>
PBMCs were derived from whole blood separated by centrifugation on a Ficoll-Hypaque gradient, plated at a density of 1x105 cells per well in 96-well plates in RPMI (supplemented with 10% fetal bovine serum), and incubated overnight. PBMC cytokine assays were then performed by stimulating with various TLR ligands or extracts of M. leprae for 18 hours. Each sample was assayed in triplicate. Cytokine levels were determined with a sandwich ELISA technique (Duoset, R&D Systems, Minneapolis, MN) or with a multiplex kit for the luminex platform (Human Fluorokine MAP Base Kit, Panel A, R&D systems, Minneapolis, MN). Levels of contaminating LPS as determined by the chromogenic Limulus amebocyte lysate test (Cambrex, MD) were 0.05-0.27, and 0.03-0.19 endotoxin units/ml, in wells incubated with whole irradiated ML (ML) and ML cell wall (MLcw), respectively, depending on the dose of reagent used. These values correspond to 4.5-27.2 and 3.04-19.4 pg/ml of endotoxin, respectively, in wells treated with whole irradiated ML and ML cw. All wells that received ML reagents were additionally treated with polymyxin B at a concentration of 10 microg/ml.
###end p 19
###begin title 20
Transfections
###end title 20
###begin p 21
###xml 117 118 117 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 374 376 <span type="species:ncbi:1769">ML</span>
HEK293 cells were transfected with Polyfect (Qiagen, Hilden, Germany) per the manufacturer's instructions with 2-5x104 cells per well in a 96-well plate with pRL-TK (to control for transfection efficiency), ELAM-luciferase (NF-kappaB reporter), one of two TLR1 variants, TLR2, and CD14. After an overnight transfection, cells were stimulated with TLR ligands or extracts of ML for 4-6 hours, and then lysed and processed for luciferase readings per the manufacturer's instructions for the Dual Luciferase Reporter Assay System (Promega, Madison, WI).
###end p 21
###begin title 22
Statistics
###end title 22
###begin p 23
###xml 828 832 826 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Mander1">[44]</xref>
Univariate analysis was performed for categorical variables with a Chi-Square test; Fisher's exact test was used when the number of samples in a group was less than 5. The Mann-Whitney U-test was used to make comparisons of the cytokine production between groups, as small sample sizes precluded an assumption of normal distribution. Student's t-test was used to compare results in the luciferase assay. Two-sided testing was used for all comparisons to evaluate statistical significance. A P value (p) of </=0.05 was considered significant. Statistics were calculated with Prism version 4.03software. For genetic analysis, allelic, genotypic, and haplotypic frequencies were compared between groups. Haplotypes were constructed with an Expectation/Maximization (EM) algorithm with the program HAPIPF in IC Stata (version 10.0) [44]. Except for minor deviations, the observed allelic frequencies of SNPs were consistent with expected frequencies under Hardy-Weinberg equilibrium.
###end p 23
###begin title 24
Results
###end title 24
###begin title 25
###xml 52 61 52 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. leprae</italic>
###xml 52 61 <span type="species:ncbi:1769">M. leprae</span>
TLR1 SNP T1805G regulates signalling in response to M. leprae in transfected cells
###end title 25
###begin p 26
###xml 220 227 212 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 309 313 301 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Hawn1">[38]</xref>
###xml 472 477 464 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000231-g001">Fig 1</xref>
###xml 805 810 789 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000231-g001">Fig 1</xref>
###xml 1263 1267 1239 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Krutzik1">[29]</xref>
###xml 1425 1430 1393 1398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000231-g001">Fig 1</xref>
###xml 1737 1741 1697 1701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Hawn1">[38]</xref>
###xml 1866 1871 1822 1827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000231-g001">Fig 1</xref>
###xml 75 77 <span type="species:ncbi:1769">ML</span>
###xml 354 356 <span type="species:ncbi:1769">ML</span>
###xml 575 577 <span type="species:ncbi:1769">ML</span>
###xml 826 828 <span type="species:ncbi:1769">ML</span>
###xml 1010 1012 <span type="species:ncbi:1769">ML</span>
###xml 1067 1069 <span type="species:ncbi:1769">ML</span>
###xml 2529 2531 <span type="species:ncbi:1769">ML</span>
We investigated the effect of SNP T1805G (I602S) on NF-kappaB responses to ML in HEK293 cells transfected with 1805T (602I) or 1805G (602S), firefly luciferase conjugated to an NF-kappaB promoter (ELAM), TLR2, CD14, and Renilla luciferase conjugated to thymidine kinase to control for transfection efficiency [38]. Cells were then stimulated with media, ML extracts or TLR ligands: PAM3, a ligand for the TLR2/1 heterodimer or Malp-2, a ligand for the TLR2/6 heterodimer (Fig 1). HEK293 cells transfected with TLR2+1805T and stimulated with 50 microg/ml of whole, irradiated ML had significantly greater NF-kappaB activity than HEK293 cells transfected with TLR2 alone (600.7 vs. 159.8 relative luciferase units (RLU), p = 0.001), or cells transfected with TLR2+1805G (600.7 vs. 157.1 RLU, p = 0.000004) (Fig 1). Responses to ML were dose-dependent in cells transfected with either TLR1 variant and the signaling difference between 1805T and 1805G transfectants persisted over a range of doses (comparison for ML 5 microg/ml: 511.9 vs. 75.8, p<0.0001; comparison for ML 250 microg/ml: 673.7 vs. 262.8, p = 0.0005). We then investigated whether T1805G influenced signaling in response to MLcw, which contains lipopeptide moieties known to stimulate through TLR2/1 [29]. TLR2+1805T-transfected cells stimulated with 1 or 10 microg/ml of MLcw had significantly greater NF-kappaB activity than cells transfected with TLR2+1805G (Fig 1, comparison for MLcw 1 microg/ml: 444.4 vs. 53.8 RLU, p = 0.00005; comparison for MLcw 10 microg/ml: 562.8 vs. 238.1 RLU, p = 0.004). As a control, we also compared baseline signalling activity and response to tri-acylated lipopeptide (PAM3) in the two 1805 variants. Consistent with previous observations [38], the 1805T variant, when co-transfected with TLR2, mediated greater constitutive NF-kappaB activity compared to TLR2 alone (Fig 1, stimulation with media alone: 329.7 vs. 3.9 RLU, p = 0.000003). The TLR2+1805T transfectants were also readily distinguished from the TLR2+1805G transfectants by a significantly higher level of basal signaling (329.7 vs. 24.2 RLU, p = 0.000002). In addition, TLR2+1805T-transfected cells stimulated with PAM3 had significantly greater NF-kappaB activity compared to cells transfected with TLR2+1805G (841.4 vs. 383.7 RLU, p = 0.0009). In contrast, responses to Malp-2 did not significantly differ between the two variants (783.1 vs. 650.6 RLU, p = 0.37). Together, these results suggest that TLR1 variant 1805G leads to impaired innate immune responses to ML because of a defect in basal signaling of the TLR2/1 heterodimer.
###end p 26
###begin title 27
###xml 34 43 30 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. leprae</italic>
###xml 34 43 <span type="species:ncbi:1769">M. leprae</span>
NF-kappaB activity in response to M. leprae is diminished in the 1805T variant.
###end title 27
###begin p 28
###xml 71 78 67 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 726 735 718 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. leprae</italic>
###xml 667 669 <span type="species:ncbi:1769">ML</span>
###xml 689 691 <span type="species:ncbi:1769">ML</span>
###xml 726 735 <span type="species:ncbi:1769">M. leprae</span>
HEK293 cells were transfected with an NF-kappaB luciferase reporter, a Renilla luciferase construct to control for transfection efficiency (pRL-TK), and CD14. Additional transfectants varied by condition and included: empty plasmid vector (EV, clear), TLR2 alone (T2, gray), or TLR2 with one of two TLR1 constructs, 1805T (black) or 1805G (stippled). Luciferase activity represents basal (media stimulation) or stimulated activity of transfected cells. Mean values (+/-standard deviation) are depicted for two representative experiments, each performed in triplicate. RLU, relative luciferase units; P3 300, PAM3 at a dose of 300 ng/ml; M2 100, Malp-2, at 100 ng/ml; ML, whole, irradiated ML at 5, 50, or 250 microg/ml; MLcw, M. leprae cell wall at a dose of 1 or 10 microg/ml. * = P</=0.01, by Student's t-test when comparing the 1805T and 1805G variants (both with T2); # = P</=0.01, by Student's t-test when comparing T2+1805T and T2; ˆ = P</=0.01, by Student's t-test when comparing T2+1805G and T2.
###end p 28
###begin title 29
###xml 55 64 55 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. leprae</italic>
###xml 55 64 <span type="species:ncbi:1769">M. leprae</span>
###xml 68 73 <span type="species:ncbi:9606">human</span>
TLR1 SNP T1805G regulates the inflammatory response to M. leprae in human monocytes
###end title 29
###begin p 30
###xml 233 237 233 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Hawn1">[38]</xref>
###xml 478 483 478 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000231-g002">Fig 2</xref>
###xml 630 636 630 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000231-g002">Fig 2B</xref>
###xml 876 882 868 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000231-g002">Fig 2B</xref>
###xml 1210 1216 1194 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000231-g002">Fig 2A</xref>
###xml 1496 1502 1476 1482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000231-g002">Fig 2A</xref>
###xml 1767 1773 1744 1750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000231-g003">Fig 3A</xref>
###xml 2086 2092 2056 2062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000231-g003">Fig 3B</xref>
###xml 2200 2206 2170 2176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000231-g003">Fig 3B</xref>
###xml 2385 2391 2352 2358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000231-g002">Fig 2B</xref>
###xml 2393 2395 2360 2362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pntd-0000231-g003">3A</xref>
###xml 74 76 <span type="species:ncbi:1769">ML</span>
###xml 80 85 <span type="species:ncbi:9606">human</span>
###xml 293 295 <span type="species:ncbi:1769">ML</span>
###xml 802 804 <span type="species:ncbi:1769">ML</span>
###xml 906 908 <span type="species:ncbi:1769">ML</span>
###xml 983 985 <span type="species:ncbi:1769">ML</span>
###xml 1717 1719 <span type="species:ncbi:1769">ML</span>
###xml 2048 2050 <span type="species:ncbi:1769">ML</span>
We next examined whether TLR1_T1805G regulates innate immune responses to ML in human primary immune cells. We obtained PBMC from whole blood from 28 healthy individuals whose genotypes for TLR1_T1805G had previously been determined [38]. The PBMCs were then stimulated with whole, irradiated ML, MLcw, and a variety of TLR ligands, including PAM3, PAM2, and LPS. We compared the high (1805TT) and medium (1805TG) responding genotypes with the low responding genotype (1805GG) (Fig 2). When stimulated with MLcw, PBMCs from 1805TT or 1805TG (1805TT/TG) donors showed significantly greater IL-6 responses compared to 1805GG PBMCs (Fig 2B, for MLcw at 2 microg/ml: 5,950 vs. 2,198 pg/ml, p = 0.0005; for MLcw at 10 microg/ml: 6,115 vs. 3,320 pg/ml, p = 0.0076). Similarly, responses to whole, irradiated ML were significantly higher in 1805TT/TG PBMCs compared to 1805GG PBMCs (Fig 2B, for whole, irradiated ML at 20 microg/ml: 3,310 vs. 1,649 pg/ml, p = 0.0005; for whole, irradiated ML at 100 microg/ml: 6,183 vs. 2,246 pg/ml, p = 0.0017). As previously observed, after stimulation with PAM3, significantly higher levels of IL-6 were seen in PBMCs heterozygous or homozygous for 1805T compared to1805GG PBMCs (Fig 2A, for TT/TG genotypes vs. GG genotypes stimulated with 75 microg/mL PAM3: 3,966 vs. 1,491 pg/ml, p = 0.0007). Stimulation with LPS and PAM2, ligands with specificity for TLR4 and TLR2/6, respectively, produced no significant differences in IL-6 production between the two groups (Fig 2A). We also assessed the levels of other cytokines important in the monocyte immune response to mycobacteria and found that IL-1beta production in PBMCs from 1805TT/TG donors stimulated with PAM3 or whole irradiated ML was significantly higher than in 1805GG PBMCs (Fig 3A). IL-1beta levels did not differ between the two groups when PBMCs were stimulated with PAM2 or with LPS (TLR2/6 and TLR4 ligands, respectively) controls. Production of TNF-alpha, similarly, was significantly higher in 1805TT/TG PBMCs stimulated with PAM3, whole irradiated ML, or MLcw compared to 1805GG PBMCs (Fig 3B), but did not differ between the two groups after stimulation with Pam2 or LPS (TLR2/6 and TLR4 controls) (Fig 3B). Interestingly, there were no differences in IL-1beta levels between TT/TG and GG groups after PBMC stimulation with MLcw, in contrast to the pattern seen with other cytokines (Fig 2B, 3A).
###end p 30
###begin title 31
###xml 66 76 66 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. leprae.</italic>
###xml 19 24 <span type="species:ncbi:9606">human</span>
###xml 66 75 <span type="species:ncbi:1769">M. leprae</span>
IL-6 production by human primary cells following stimulation with M. leprae.
###end title 31
###begin p 32
###xml 498 500 <span type="species:ncbi:1769">ML</span>
Peripheral blood mononuclear cells were stimulated for 18 hours and supernatants were assayed for cytokine production by ELISA. PBMCs were derived from whole blood taken from 15 individuals with the genotype 1805TTor 1805TG (TT/TG: dark circles) and 13 individuals with the 1805GG genotypes (GG: open circles). (A): PBMCs stimulated in triplicate with media, PAM2 at 75 ng/ml (P2 75), PAM3 at 75 ng/ml (P3 75), or LPS at 10 ng/ml (LPS 10). (B): PBMCs stimulated in triplicate with whole irradiated ML at 20 or 100 microg/ml (ML20 or ML100) or MLcw at 2 or 10 microg/ml (MLcw 2 or MLcw10). The mean level and standard error of the mean are depicted and were derived from averaging the responses of individuals stimulated in triplicate. The median level is depicted by a bar. *P</=0.01, **P</=0.001 by Mann-Whitney U-test.
###end p 32
###begin title 33
###xml 87 96 80 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. leprae</italic>
###xml 36 41 <span type="species:ncbi:9606">human</span>
###xml 87 96 <span type="species:ncbi:1769">M. leprae</span>
IL-beta and TNF-alpha production in human mononuclear cells following stimulation with M. leprae.
###end title 33
###begin p 34
###xml 431 433 <span type="species:ncbi:1769">ML</span>
###xml 451 453 <span type="species:ncbi:1769">ML</span>
Peripheral blood mononuclear cells were stimulated for 18 hours and supernatants were assayed for cytokine production by luminex multiplex bead assay. PBMCs were obtained from 11 individuals with the genotype 1805TT or 1805TG (TT/TG: dark circles) and 10 individuals with the 1805GG genotypes (GG: open circles). PBMCs stimulated with media, PAM2 at 75 ng/mL (P2), PAM3 at 75 ng/mL (P3), or LPS at 10 ng/ml (LPS), whole irradiated ML at 20 microg/ml (ML) or MLcw at 10 microg/ml (MLcw). IL-1beta production following stimulation is shown in (A), and TNF-alpha production in (B). The mean level and standard error of the mean are depicted and were derived from averaging the responses of individual within each genotype group. The median level is depicted by a bar; *p</=0.05, **p</=0.001 by Mann-Whitney U-test.
###end p 34
###begin title 35
TLR1 is not associated with altered risk of tuberculoid or lepromatous forms of leprosy
###end title 35
###begin p 36
###xml 895 902 895 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000231-t001">Table 1</xref>
###xml 1135 1142 1135 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000231-t002">Table 2</xref>
###xml 1552 1559 1552 1559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000231-t002">Table 2</xref>
###xml 340 348 <span type="species:ncbi:9606">patients</span>
###xml 649 657 <span type="species:ncbi:9606">patients</span>
Although recently published data suggests that TLR1_T1805G is associated with susceptibility to leprosy, associations with different types of leprosy or immunologic reactions have not been previously examined. To determine whether the TLR1_T1805G polymorphism was associated with different forms of leprosy or leprosy immune reactions, 933 patients from Anandaban Hospital in Kathmandu, Nepal were enrolled in a retrospective study. Of this total, 581 had polar lepromatous (LL), borderline leprosy (BL) or borderline borderline (BB) and 343 had tuberculoid leprosy (including borderline tuberculoid (BT) and polar tuberculoid (TT)). A total of 344 patients experienced immune reactions during 3 years of regular visits to a leprosy clinic, of whom 238 had RR and 108 had erythema nodosum leprosum (ENL) and 2 had both reactions. The baseline characteristics of this population are described in Table 1. When individuals with lepromatous leprosy were compared to those with tuberculoid leprosy, there were no significant associations between SNP T1805G and either form of leprosy, either at the allelic or genotypic level of analysis (Table 2). However, there was a trend toward an association of the TG or GG genotypes with lepromatous leprosy (OR [odds ratio] 4.76, 95% CI [95% confidence interval] 0.58-38.87, p = 0.11) in comparison to tuberculoid leprosy that did not reach significance. We also genotyped five additional TLR1 SNPs that are contained in common TLR1 haplotypes. We did not find associations of any of these SNPs with leprosy type (Table 2). Analysis of TLR1 haplotypes generated from these six SNPs similarly yielded no association with leprosy type (data not shown).
###end p 36
###begin title 37
Baseline characteristics of leprosy subjects.
###end title 37
###begin p 38
Percentages of individuals in some categories do not sum to 100 due to missing data. Not shown among all leprosy are 8 subjects with peripheral neuropathy (PN), and one with leprosy of indeterminate type (IN).
###end p 38
###begin p 39
The four most frequent ethnic groups (from > 8 ethnic groups) are tabulated.
###end p 39
###begin p 40
###xml 19 20 19 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
P represents exact P values for overall distribution of gender and age groups within the different ethnic groups and for the overall distribution of leprosy type and immune reactions among the 4 different ethnic groups.
###end p 40
###begin title 41
TLR1 Polymorphism Frequency in Different Leprosy Types.
###end title 41
###begin p 42
P value for comparison of allele frequencies.
###end p 42
###begin p 43
P value for comparison of genotype frequencies.
###end p 43
###begin p 44
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>A</italic></bold>
###xml 25 26 25 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 25 26 25 26 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>a</italic></bold>
A denotes common allele, a denotes minor allele.
###end p 44
###begin p 45
Tuberculoid includes TT and BT. Lepromatous includes LL, BL, and BB.
###end p 45
###begin title 46
TLR1 variant 1805G is associated with protection from reversal reaction
###end title 46
###begin p 47
###xml 371 378 371 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000231-t003">Table 3</xref>
###xml 618 625 618 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000231-t003">Table 3</xref>
###xml 1002 1009 1002 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000231-t001">Table 1</xref>
We next investigated whether T1805G (I602S) might be associated with ENL or RR, a Th1-mediated immune event clinically manifested by inflamed skin lesions, fever, and neuritis. There was no association of T1805G or any other TLR1 polymorphisms with ENL. In contrast, the 1805G allele was associated with a reduced risk of developing RR in comparison to the 1805T allele (Table 3). The allele frequency of 1805G was 3.9% in those with RR versus 7.4% in those without (unadjusted OR 0.51, 95% CI 0.29-0.87, p = 0.01). The distribution of the genotype frequencies was also significantly different with a p value of 0.05 (Table 3). We next examined whether this association was affected by population admixture. This cohort contains representatives of more than 8 different ethnic groups with the majority belonging to one of four groups (Brahmin, Chhetri, Tamang, and Newar). There were no significant differences in frequencies of leprosy type or immunologic reactions among the different ethnic groups (Table 1). We performed a multivariate logistic regression, adjusting for ethnicity, and found that the odds ratio remained significant (OR 0.52, 95% CI 0.30-0.92, p = 0.03). We also adjusted for ethnicity, sex and age as a continuous variable, and again found that the odds ratio remained significant (OR 0.54, 95% CI, 0.30-0.96, p = 0.04).
###end p 47
###begin title 48
TLR1 Polymorphism Frequency in Reversal Reaction.
###end title 48
###begin p 49
P value for comparison of allele frequencies by Chi-square.
###end p 49
###begin p 50
P value for comparison of genotype frequencies calculated by Chi-square unless otherwise indicated.
###end p 50
###begin p 51
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>A</italic></bold>
###xml 25 26 25 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 25 26 25 26 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>a</italic></bold>
A denotes common allele, a denotes minor allele.
###end p 51
###begin p 52
P value calculated by Fisher's Exact test due to small cell number.
###end p 52
###begin p 53
###xml 121 125 121 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Hawn1">[38]</xref>
Previously, we found that TG individuals are intermediate between TT and GG individuals in responses to TLR1 stimulation [38]. We therefore investigated the influence of TG heterozygotes with a recessive (assumes T is recessive to G and compares TT versus TG/GG frequencies) or a dominant model (assumes T is dominant over G and compares TT/TG versus GG frequencies). In the recessive model, we found that the 1805 TG/GG genotypes were associated with a lower likelihood of RR compared to the TT genotype (OR 0.55, 95% CI 0.31-0.97, p = 0.04). In the dominant model, the GG genotype was associated with a non-significant reduction in risk when compared to the TT/TG genotypes (OR 0.15, 95%CI 0.01-2.62, p = 0.12).
###end p 53
###begin p 54
###xml 280 287 280 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000231-t003">Table 3</xref>
###xml 397 404 397 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000231-t004">Table 4</xref>
###xml 901 908 901 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pntd-0000231-t004">Table 4</xref>
We next examined other TLR1 polymorphisms to determine whether there were any additional associations between individual SNPs or haplotypes and RR. SNP rs5743592, located in intron 2 adjacent to the 5' UTR of TLR1, was found to be associated with a modestly increased risk of RR (Table 3, OR for allelic comparison: 1.29, 95% CI 1.02-1.64, p = 0.04). When haplotypes of 6 TLR1 SNPs were examined (Table 4), one haplotype, TATTAG, was associated with protection from RR (OR 0.55, 95% CI 0.31-0.97, p = 0.05). None of the other five haplotypes had any association with RR. Haplotype TATTAG was the only haplotype occurring with a frequency greater than 1% that contained the 1805G allele. Lastly, we examined whether haplotypes formed from SNPs rs5743592 and 1805 were associated with altered risk of RR. The haplotype associations were consistent with the individual effect of each SNP on the risk RR (Table 4), without any additive or synergistic effects. Together, these genetic data demonstrate that TLR1 SNP 1805G is associated with protection from RR.
###end p 54
###begin title 55
Frequency of TLR1 haplotypes in reversal reaction.
###end title 55
###begin p 56
Order for 6 SNP haplotypes, left to right: Trs5743563C, Ars5743565G, Trs5743592C, Trs5743595C, G743A, T1805G.
###end p 56
###begin p 57
Order for 2 SNP haplotypes: Trs5743592C, T1805G.
###end p 57
###begin p 58
P value represents comparison of a given haplotype with the reference haplotype TATTAT.
###end p 58
###begin title 59
Discussion
###end title 59
###begin p 60
###xml 614 618 614 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Johnson1">[39]</xref>
###xml 42 47 <span type="species:ncbi:9606">human</span>
###xml 97 99 <span type="species:ncbi:1769">ML</span>
###xml 730 736 <span type="species:ncbi:9103">Turkey</span>
###xml 806 813 <span type="species:ncbi:9606">patient</span>
In this manuscript, we demonstrate that a human TLR1 SNP regulates the innate immune response to ML and is associated with protection from RR. This is the first study to describe an association of a TLR1 SNP with a Th1-mediated adaptive immune response. One weakness of our study is the low frequency of the 1805G variant in Nepal, which limited our power to detect associations with leprosy type. However, the relevance of the 1805G SNP to leprosy pathogenesis is supported by work from Johnson and colleagues, who recently reported an association of this variant with protection from leprosy in a Turkish cohort [39]. Although these authors do not mention whether or not T1805G was associated with different forms of leprosy in Turkey or with immune reactions, this may be due to the small size of their patient cohort (57 individuals). Genetic association studies that utilize cohorts of multiple ethnicities are also open to the criticism that associations are due to the effects of population admixture rather than the variant of interest. However, when we adjusted for ethnic composition of the comparision groups, we still found that the 1805G variant was associated with significant protection against RR.
###end p 60
###begin p 61
###xml 454 463 454 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. leprae</italic>
###xml 648 652 648 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Pulendran1">[35]</xref>
###xml 653 657 653 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Pasare1">[36]</xref>
###xml 831 835 831 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Noss1">[45]</xref>
###xml 978 982 978 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Murray1">[46]</xref>
###xml 1126 1130 1126 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Yamamura1">[47]</xref>
###xml 1131 1135 1131 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Krutzik2">[48]</xref>
###xml 1387 1396 1387 1396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. leprae</italic>
###xml 1550 1554 1550 1554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Krutzik2">[48]</xref>
###xml 454 463 <span type="species:ncbi:1769">M. leprae</span>
###xml 694 697 <span type="species:ncbi:1773">MTb</span>
###xml 867 869 <span type="species:ncbi:1769">ML</span>
###xml 990 998 <span type="species:ncbi:9606">patients</span>
###xml 1223 1231 <span type="species:ncbi:9606">patients</span>
###xml 1387 1396 <span type="species:ncbi:1769">M. leprae</span>
There are several possible mechanisms by which TLR1 might affect the pathogenesis of RR. At the cellular level, TLR1 might exert its influence through control of innate immune functions, such as the capacity of dendritic cells (DCs) and macrophages to control bacillary replication. Alternatively, or in addition, SNP 1805 may regulate DC maturation and/or antigen presentation and thereby influence the activation and maintenance of T cell responses to M. leprae antigens. Interestingly, recent work by other investigators demonstrates that the differentiation of monocytes into mature antigen presenting cells (APCs) is mediated by TLR signaling [35],[36]. For example, the 19 kDa protein of MTb signals through TLR2/1 to downregulate MHC class I and II antigen presentation by macrophages, leading to impaired T cell activation [45]. We have previously shown that ML also exerts an inhibitory effect on APC activation and maturation, through an as-yet unidentified mechanism [46]. In LL patients who are clinically stable, macrophages within LL lesions contain numerous bacilli that are seemingly resistant to host killing [47],[48]. However, this inhibition of phagocyte function seems to be overturned during RR. When patients undergo RR, the bacilli within these macrophages are rapidly cleared. This clearance coincides with the influx into the lesion of CD1b+ DC, which activate M. leprae-specific T cells and thereby promote intracellular killing. Importantly, the generation of CD1b+ DCs appears to be dependent on signaling through TLR2/1 [48]. Here, we show that individuals carrying the 1805G SNP are protected against reversal reactions. Our data suggests that TLR1 may be an important regulator of these effects on DCs.
###end p 61
###begin p 62
###xml 271 275 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Johnson1">[39]</xref>
###xml 766 770 766 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Krutzik1">[29]</xref>
###xml 1138 1147 1138 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. leprae</italic>
###xml 1138 1147 <span type="species:ncbi:1769">M. leprae</span>
At the molecular level, the defect in 1805G signaling is likely due to a failure to express or retain TLR1 on the cell surface. Johnson recently showed that monocytes from 1805GG individuals completely lack surface TLR1, although total levels of this receptor are normal [39]. In Nepal, we observed a trend toward an association of the 1805G variant with lepromatous rather than tuberculoid leprosy. This trend, although not statistically significant, is consistent with impaired Th1 immunity, which is required for the tuberculoid form of the disease. An association of 1805G with lepromatous leprosy could explain the intriguing earlier observation by Krutzik and coworkers, who examined TT and LL lesions and were unable to detect any TLR1 staining in LL lesions [29]. Collectively, these findings suggest that TLR1 biology is different in lepromatous leprosy than in other forms of the disease. The absence of membrane-inserted TLR1 in 1805GG individuals may be associated with a Th2 immune response that arises by default in the absence of robust Th1 cytokine responses. This Th2 bias may in turn permit continued replication of the M. leprae bacillus and result in the clinical phenotype of LL.
###end p 62
###begin p 63
###xml 204 208 204 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Hawn1">[38]</xref>
###xml 345 349 345 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Johnson1">[39]</xref>
###xml 456 460 456 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Hawn1">[38]</xref>
###xml 666 670 666 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pntd.0000231-Underhill2">[49]</xref>
###xml 293 299 <span type="species:ncbi:9103">Turkey</span>
In our initial characterization of TLR1_T1805G, we found that this polymorphism is present in up to 76% of Caucasian Americans and is associated with a defect in innate responses to bacterial lipopeptide [38]. Worldwide, the T1805G polymorphism has variable frequency across ethnic groups. In Turkey, the allele frequency of this variant is 43% [39], while among African Americans and Vietnamese individuals, it has a frequency of 25% and 1%, respectively [38]. A broad array of pathogens are sensed by TLR2, and consequently by TLR2/1 or TLR2/6 heterodimers. These microorganisms include gram-positive and gram-negative bacteria, fungi, parasites, and mycobacteria [49]. Given the association of TLR1 1805G with Th1-mediated immune events, this SNP may influence the pathogenesis of any number of inflammatory conditions, including chronic mycobacterial infection, autoimmune disorders, sepsis and allergic reactions.
###end p 63
###begin p 64
###xml 56 58 <span type="species:ncbi:1769">ML</span>
###xml 175 183 <span type="species:ncbi:9606">patients</span>
We thank John Spencer and Patrick Brennan for providing ML reagents. We thank the staff at Anandaban Hospital for the clinical work associated with this study and the leprosy patients for participation in this study. We thank Carey Cassidy for technical assistance.
###end p 64
###begin title 65
References
###end title 65
###begin article-title 66
###xml 0 26 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter?
###end article-title 66
###begin article-title 67
###xml 52 57 <span type="species:ncbi:9606">human</span>
Genetic dissection of immunity to mycobacteria: the human model.
###end article-title 67
###begin article-title 68
###xml 51 57 <span type="species:ncbi:9606">humans</span>
Genetic susceptibility to mycobacterial disease in humans.
###end article-title 68
###begin article-title 69
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human genetics of common mycobacterial infections.
###end article-title 69
###begin article-title 70
Genetic dissection of immunity in leprosy.
###end article-title 70
###begin article-title 71
A Twin Study on Leprosy.
###end article-title 71
###begin article-title 72
###xml 86 106 <span type="species:ncbi:1769">Mycobacterium leprae</span>
Genetic predisposition to leprosy: A major gene reveals novel pathways of immunity to Mycobacterium leprae.
###end article-title 72
###begin article-title 73
A major susceptibility locus for leprosy in India maps to chromosome 10p13.
###end article-title 73
###begin article-title 74
Stepwise replication identifies a low-producing lymphotoxin-[alpha] allele as a major risk factor for early-onset leprosy.
###end article-title 74
###begin article-title 75
Association of Vitamin D Receptor Genotype with Leprosy Type.
###end article-title 75
###begin article-title 76
Role of Tumor Necrosis Factor-alpha and Interleukin-10 Promoter Gene Polymorphisms in Leprosy.
###end article-title 76
###begin article-title 77
###xml 109 117 <span type="species:ncbi:9606">patients</span>
Association of a missense mutation of the laminin alpha2 gene with tuberculoid type of leprosy in Indonesian patients.
###end article-title 77
###begin article-title 78
The association between mannan-binding lectin gene polymorphism and clinical leprosy: new insight into an old paradigm.
###end article-title 78
###begin article-title 79
Mannan-binding lectin plasma levels in leprosy: deficiency confers protection against the lepromatous but not the tuberculoid forms.
###end article-title 79
###begin article-title 80
The Continuing Challenges of Leprosy.
###end article-title 80
###begin article-title 81
Leprosy.
###end article-title 81
###begin article-title 82
###xml 91 99 <span type="species:ncbi:9606">Patients</span>
Age Is an Important Risk Factor for Onset and Sequelae of Reversal Reactions in Vietnamese Patients with Leprosy.
###end article-title 82
###begin article-title 83
Ninjurin 1 asp110ala single nucleotide polymorphism is associated with protection in leprosy nerve damage.
###end article-title 83
###begin article-title 84
Toll-Like Receptor 2 (TLR2) Polymorphisms Are Associated with Reversal Reaction in Leprosy.
###end article-title 84
###begin article-title 85
Toll-like receptor signalling.
###end article-title 85
###begin article-title 86
Toll-like receptor control of the adaptive immune responses.
###end article-title 86
###begin article-title 87
Inferences, questions and possibilities in Toll-like receptor signalling.
###end article-title 87
###begin article-title 88
Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages.
###end article-title 88
###begin article-title 89
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 57 83 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Human Toll-Like Receptors Mediate Cellular Activation by Mycobacterium tuberculosis.
###end article-title 89
###begin article-title 90
###xml 89 115 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis.
###end article-title 90
###begin article-title 91
Mycobacterial lipoarabinomannan mediates physical interactions between TLR1 and TLR2 to induce signaling.
###end article-title 91
###begin article-title 92
The role of Toll-like receptors in immunity against mycobacterial infection.
###end article-title 92
###begin article-title 93
Toll-like receptor pathways in the immune responses to mycobacteria.
###end article-title 93
###begin article-title 94
###xml 60 65 <span type="species:ncbi:9606">human</span>
Activation and regulation of Toll-like receptors 2 and 1 in human leprosy.
###end article-title 94
###begin article-title 95
Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling.
###end article-title 95
###begin article-title 96
###xml 34 39 <span type="species:ncbi:9606">human</span>
The Arg753Gln polymorphism of the human Toll-like receptor 2 gene in tuberculosis disease.
###end article-title 96
###begin article-title 97
###xml 18 23 <span type="species:ncbi:9606">human</span>
A polymorphism in human TLR2 is associated with increased susceptibility to tuberculous meningitis.
###end article-title 97
###begin article-title 98
###xml 73 78 <span type="species:ncbi:9606">human</span>
The association between microsatellite polymorphisms in intron II of the human Toll-like receptor 2 gene and tuberculosis among Koreans.
###end article-title 98
###begin article-title 99
Cutting Edge: Different Toll-Like Receptor Agonists Instruct Dendritic Cells to Induce Distinct Th Responses via Differential Modulation of Extracellular Signal-Regulated Kinase-Mitogen-Activated Protein Kinase and c-Fos.
###end article-title 99
###begin article-title 100
Modulating vaccine responses with dendritic cells and Toll-like receptors.
###end article-title 100
###begin article-title 101
Toll-like receptors and acquired immunity.
###end article-title 101
###begin article-title 102
Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling.
###end article-title 102
###begin article-title 103
###xml 9 14 <span type="species:ncbi:9606">human</span>
A common human TLR1 polymorphism regulates the innate immune response to lipopeptides.
###end article-title 103
###begin article-title 104
Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy.
###end article-title 104
###begin article-title 105
A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease.
###end article-title 105
###begin article-title 106
Classification of leprosy according to immunity. A five-group system.
###end article-title 106
###begin article-title 107
Hyper-IgE Syndrome Is Not Associated With Defects in Several Candidate Toll-Like Receptor Pathway Genes.
###end article-title 107
###begin article-title 108
MALDI-TOF mass spectrometry-based SNP genotyping.
###end article-title 108
###begin article-title 109
Haplotype analysis in population-based association studies.
###end article-title 109
###begin article-title 110
###xml 128 154 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Toll-Like Receptor 2-Dependent Inhibition of Macrophage Class II MHC Expression and Antigen Processing by 19-kDa Lipoprotein of Mycobacterium tuberculosis.
###end article-title 110
###begin article-title 111
###xml 0 20 <span type="species:ncbi:1769">Mycobacterium leprae</span>
Mycobacterium leprae Inhibits Dendritic Cell Activation and Maturation.
###end article-title 111
###begin article-title 112
Defining protective responses to pathogens: cytokine profiles in leprosy lesions.
###end article-title 112
###begin article-title 113
TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells.
###end article-title 113
###begin article-title 114
The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens.
###end article-title 114
###begin p 115
The authors have declared that no competing interests exist.
###end p 115
###begin p 116
This work was supported by The Heiser Program for Research in Tuberculosis and Leprosy with a grant to EAM and TRH, the National Institutes of Health with grants to GK (AI 22616 and AI 54361), the Dana Foundation to TRH, and the Leprosy Mission International to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 116

